Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study. (Q47870184)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

title

Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Icro Meattini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Peter Bult

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

James B Yu

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

author name string

P Jain

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

N Simone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

I Kindts

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

R Steffens

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

C Weltens

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

P Navarria

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Y Belkacemi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

J Lopez-Guerra

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

L Livi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

B G Baumert

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

B Vieites

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

D Limon

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

N Kurman

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

K Ko

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

V Chiang

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

P Poortmans

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

T Zagar

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

language of work or name

English

0 references

publication date

3 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

31 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

volume

167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

page(s)

479-483

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-017-4526-8

31 March 2020

exact match

0 references

cites work

Epidemiology of metastatic brain tumors

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

Immunohistochemical profiles of brain metastases from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

CNS metastases of breast cancer show discordant immunohistochemical phenotype compared to primary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

Primary breast cancer phenotypes associated with propensity for central nervous system metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

Discordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-017-4526-8

10.1007/S10549-017-4526-8

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28975433%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference